4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-26-022628
Chief Operating Officer gave up 2,309 shares (to pay taxes)
- Chief Operating Officer acquired 5,254 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cittadine Andrew · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-30 | Exercise or conversion : show line 1 in the form | +5,254 | 57,923 | D | ||
| 2026-06-30 | Shares withheld for taxes : show line 2 in the form | −2,309 | $92.59 | $213,790 | 55,614 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-30 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −5,254 | 39,499 | D |
Loading xslF345X06/rdgdoc.xml…